Literature DB >> 32259841

Early net ultrafiltration rate and mortality in critically ill patients receiving continuous renal replacement therapy.

Thummaporn Naorungroj1,2, Ary Serpa Neto1,3,4, Lara Zwakman-Hessels1,5, Fumitaka Yanase1,6, Glenn Eastwood1, Raghavan Murugan7,8, John A Kellum7,8, Rinaldo Bellomo1,9,10.   

Abstract

BACKGROUND: In patients treated with continuous renal replacement therapy (CRRT), early net ultrafiltration (NUF) rates may be associated with differential outcomes. We tested whether higher early NUF rates are associated with increased mortality in CRRT patients.
METHODS: We performed a retrospective, observational study of all patients treated with CRRT within 14 days of intensive care unit admission. We defined the early (first 48 h) NUF rate as the volume of fluid removed per hour adjusted for patient body weight and analysed as a categorical variable (>1.75, 1.01-1.75 and <1.01 mL/kg/h). The primary outcome was 28-day mortality. To deal with competing risk, we also compared different time epochs.
RESULTS: We studied 347 patients {median age 64 [interquartile range (IQR) 53-71] years and Acute Physiology and Chronic Health Evaluation III score 73 [IQR 54-90]}. Compared with NUF rates <1.01 mL/kg/h, NUF rates >1.75 mL/kg/h were associated with greater mortality rates in each epoch: Days 0-5, adjusted hazard ratio (aHR) 1.27 [95% confidence interval (CI) 1.21-1.33]; Days 6-10, aHR 1.62 (95% CI 1.55-1.68); Days 11-15, aHR 1.87 (95% CI 1.79-1.94); Days 16-26, aHR 1.92 (95% CI 1.84-2.01) and Days 27-28, aHR 4.18 (95% CI 3.98-4.40). For every 0.5 mL/kg/h NUF rate increase, mortality similarly increased during these epochs.
CONCLUSION: Compared with early NUF rates <1.01 mL/kg/h, NUF rates >1.75 mL/kg/h are associated with increased mortality. These observations provide the rationale for clinical trials to confirm or refute these findings.
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  CRRT; continuous renal replacement therapy; mortality; net ultrafiltration

Year:  2021        PMID: 32259841     DOI: 10.1093/ndt/gfaa032

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

Review 1.  How To Prescribe And Troubleshoot Continuous Renal Replacement Therapy: A Case-Based Review.

Authors:  Javier A Neyra; Lenar Yessayan; Melissa L Thompson Bastin; Keith M Wille; Ashita J Tolwani
Journal:  Kidney360       Date:  2020-12-14

Review 2.  Kidney Replacement Therapy for Fluid Management.

Authors:  Vikram Balakumar; Raghavan Murugan
Journal:  Crit Care Clin       Date:  2021-02-13       Impact factor: 3.598

3.  Net ultrafiltration prescription survey in Europe.

Authors:  Nuttha Lumlertgul; Raghavan Murugan; Nina Seylanova; Patricia McCready; Marlies Ostermann
Journal:  BMC Nephrol       Date:  2020-12-01       Impact factor: 2.388

4.  Survey of U.S. Critical Care Practitioners on Net Ultrafiltration Prescription and Practice among Critically Ill Patients Receiving Kidney Replacement Therapy.

Authors:  Huiwen Chen; Raghavan Murugan
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-11-06

5.  The Association of an Early Net Ultrafiltration Rate and 28-Day Mortality in Patients Receiving Continuous Kidney Replacement Therapy.

Authors:  Buyun Wu; Yining Shen; Yudie Peng; Changying Xing; Huijuan Mao
Journal:  Front Med (Lausanne)       Date:  2021-12-02

6.  Ultrafiltration in Japanese critically ill patients with acute kidney injury on renal replacement therapy.

Authors:  Koichi Kitamura; Koichi Hayashi; Shigeki Fujitani; Raghavan Murugan; Toshihiko Suzuki
Journal:  J Intensive Care       Date:  2021-12-20

7.  Dose Optimization of Teicoplanin for Critically Ill Patients With Renal Dysfunction and Continuous Renal Replacement Therapy: Experience From a Prospective Interventional Study.

Authors:  Lu Shi; Zhiwei Zhuang; Lufen Duan; Chenqi Zhu; Hongzhi Xue; Xiao Wang; Xiaowen Xu; Yunlong Yuan; Ling Shi; Jiahui Li; Jiantong Sun; Xin Liu; Qin Zhou; Jian Lu; Lian Tang
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

8.  Assessment of prescribed vs. achieved fluid balance during continuous renal replacement therapy and mortality outcome.

Authors:  Javier A Neyra; Joshua Lambert; Victor Ortiz-Soriano; Daniel Cleland; Jon Colquitt; Paul Adams; Brittany D Bissell; Lili Chan; Girish N Nadkarni; Ashita Tolwani; Stuart L Goldstein
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

9.  Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study.

Authors:  Raghavan Murugan; Samantha J Kerti; Chung-Chou H Chang; Martin Gallagher; Ary Serpa Neto; Gilles Clermont; Claudio Ronco; Paul M Palevsky; John A Kellum; Rinaldo Bellomo
Journal:  Blood Purif       Date:  2021-07-21       Impact factor: 3.348

10.  Early restrictive fluid balance is associated with lower hospital mortality independent of acute disease severity in critically ill patients on CRRT.

Authors:  Panu Uusalo; Tapio Hellman; Eliisa Löyttyniemi; Julia Peltoniemi; Mikko J Järvisalo
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.